TACN vs. ARKG
TACN (T. Rowe Price Active Core International Equity ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - TACN is a Actively Managed fund actively managed by T. Rowe Price, while ARKG is a Health & Biotech Equities fund actively managed by ARK. Both are actively managed. Their 0.46 correlation means their historical movements had little consistent relationship. TACN charges 0.20%/yr vs 0.75%/yr for ARKG.
Performance
TACN vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TACN achieves a 10.54% return, which is significantly lower than ARKG's 29.44% return.
TACN
- 1D
- -0.46%
- 1M
- 0.08%
- 6M
- 4.64%
- YTD
- 10.54%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
ARKG
- 1D
- -0.85%
- 1M
- -11.47%
- 6M
- 19.12%
- YTD
- 29.44%
- 1Y
- 52.32%
- 3Y*
- 0.19%
- 5Y*
- -14.86%
- 10Y*
- 7.89%
- ALL TIME*
- 5.94%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $103.82M | $130.27M | $121.59M | |
| $184.69K | $112.68K | $82.44K |
TACN vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TACN T. Rowe Price Active Core International Equity ETF | 10.54% | 1.68% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 29.44% | -7.06% |
Correlation
The correlation between TACN and ARKG is 0.46, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Dec 11, 2025 | 0.46 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TACN vs. ARKG — Risk / Return Rank
TACN
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ARKG
TACN vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Active Core International Equity ETF (TACN) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TACN | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.22 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 1.91 | — |
| Martin ratioReturn relative to average drawdown | — | 4.59 | — |
Loading charts...
Drawdowns
TACN vs. ARKG - Drawdown Comparison
The maximum TACN drawdown since its inception was -10.98%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for TACN and ARKG.
Loading charts...
Drawdown Indicators
| TACN | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -10.98% | -83.59% | +72.61% |
Max Drawdown (1Y)Largest decline over 1 year | — | -27.51% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -51.74% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -79.26% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -1.53% | -66.45% | +64.92% |
Average DrawdownAverage peak-to-trough decline | -2.32% | -36.25% | +33.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 11.44% | — |
Volatility
TACN vs. ARKG - Volatility Comparison
Loading charts...
Volatility by Period
| TACN | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.17% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 31.06% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.14% | 43.05% | -25.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.14% | 46.14% | -29.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.14% | 41.42% | -24.28% |
TACN vs. ARKG - Expense Ratio Comparison
TACN has a 0.20% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
TACN vs. ARKG - Dividend Comparison
Neither TACN nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
TACN T. Rowe Price Active Core International Equity ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TACN and ARKG have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TACN is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TACN is cheaper with a 0.20% expense ratio, compared with 0.75% for ARKG.
TACN and ARKG have nearly identical dividend yields, around 0.00%.
TACN is categorized as Actively Managed, while ARKG is Health & Biotech Equities. They also come from different issuers: T. Rowe Price and ARK. Their fees differ too: 0.20% for TACN and 0.75% for ARKG.
Find the right allocation for TACN and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer